Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Language
Publication year range
1.
Braz J Med Biol Res ; 35(3): 377-81, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11887217

ABSTRACT

Sm14 is a 14-kDa vaccine candidate antigen from Schistosoma mansoni that seems to be involved in cytoplasmic trafficking of fatty acids. Although schistosomes have a high requirement for lipids, they are not able to synthesize fatty acids and sterols de novo. Thus, they must acquire host lipids. In order to determine whether Sm14 is present in different stages of the life cycle of the parasite, we performed RT-PCR. Sm14 mRNA was identified in all stages of the life cycle studied, mainly schistosomulum, adult worm and egg. Additionally, we used a rabbit anti-Sm14 polyclonal antibody in an indirect immunofluorescence assay to localize Sm14 in adult worm sections. The basal lamella of the tegument and the gut epithelium were strongly labeled. These tissues have a high flow of and demand for lipids, a finding that supports the putative role of Sm14 as an intracellular transporter of fatty acids from host cells.


Subject(s)
Carrier Proteins/analysis , Helminth Proteins/analysis , Membrane Transport Proteins , Neoplasm Proteins , Nerve Tissue Proteins , Schistosoma mansoni/metabolism , Animals , Antibodies, Helminth/immunology , DNA, Complementary , Fatty Acid Transport Proteins , Fatty Acid-Binding Protein 7 , Fatty Acid-Binding Proteins , Female , Fluorescent Antibody Technique, Indirect , Gene Expression , Helminth Proteins/genetics , Helminth Proteins/physiology , Life Cycle Stages , Male , Mice , Mice, Inbred BALB C , Protozoan Vaccines/immunology , Rabbits , Reverse Transcriptase Polymerase Chain Reaction , Schistosoma mansoni/genetics , Schistosoma mansoni/growth & development , Schistosomiasis mansoni/immunology
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;35(3): 377-381, Mar. 2002. ilus
Article in English | LILACS | ID: lil-304675

ABSTRACT

Sm14 is a 14-kDa vaccine candidate antigen from Schistosoma mansoni that seems to be involved in cytoplasmic trafficking of fatty acids. Although schistosomes have a high requirement for lipids, they are not able to synthesize fatty acids and sterols de novo. Thus, they must acquire host lipids. In order to determine whether Sm14 is present in different stages of the life cycle of the parasite, we performed RT-PCR. Sm14 mRNA was identified in all stages of the life cycle studied, mainly schistosomulum, adult worm and egg. Additionally, we used a rabbit anti-Sm14 polyclonal antibody in an indirect immunofluorescence assay to localize Sm14 in adult worm sections. The basal lamella of the tegument and the gut epithelium were strongly labeled. These tissues have a high flow of and demand for lipids, a finding that supports the putative role of Sm14 as an intracellular transporter of fatty acids from host cells


Subject(s)
Animals , Male , Female , Mice , Rabbits , Helminth Proteins , Schistosoma mansoni , Schistosomiasis mansoni , Antibodies, Helminth , Carrier Proteins , DNA, Complementary , Fluorescent Antibody Technique, Indirect , Gene Expression , Helminth Proteins , Life Cycle Stages , Mice, Inbred BALB C , Reverse Transcriptase Polymerase Chain Reaction , Schistosoma mansoni , Vaccines
SELECTION OF CITATIONS
SEARCH DETAIL